Back to Market Feed

RELEXXII ER 27 MG TABLET

methylphenidate hydrochloride
$11.6437per EA
High Outlier
DEA Schedule CII

Strength

27 mg/1

NDC

68025009630

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

10/22/2025

Approval Type

New Drug (NDA)

FDA Application

NDA216117

On Market Since

6/23/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

+0.3%

Generic Alternatives

1 alternative • Same active ingredient

RELEXXII ER 27 MG TABLET
Brand
68025009610•Vertical Pharmaceuticals, LLC
$11.6437

Related Drugs

Same classification

EXCEDRIN EXTRA STRENGTH GELTAB
Brand
00067202124•Haleon US Holdings LLC
$0.1205
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200020•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200024•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200033•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200050•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200077•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200091•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE GELTAB
Brand
00067203520•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203924•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203933•Haleon US Holdings LLC
$0.1338
per EA